Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 58,064,970 |
|
|||||
| News | - | ||||||
| Day High | 0.275 | Low High |
|||||
| Day Low | 0.2583 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Jaguar Health Inc | JAGX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.1492 | -52.04% | 0.1375 | 18:59:58 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.2739 | 0.2583 | 0.275 | 0.2585 | 0.2867 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 28,892 | 58,064,970 | US$ 0.2662638 | US$ 15,460,600 | - | 0.0512 - 0.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:58 | formt | 1,000 | US$ 0.1375 | USD |
Jaguar Health Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 13.2M | 50.76M | - | 9.76M | -41.3M | -0.81 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Jaguar Health News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/14/2024 | 05:41 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/10/2024 | 16:07 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 3/08/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 06:00 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 3/01/2024 | 16:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/16/2024 | 15:13 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/01/2023 | 16:25 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/30/2023 | 07:10 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
| 11/14/2023 | 20:00 | PR Newswire (Canada) | FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL.. |
| 11/08/2023 | 16:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/05/2023 | 16:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/21/2023 | 06:30 | PR Newswire (Canada) | FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JAGX Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3042 | 0.3349 | 0.25 | 0.2791336 | 34,300,637 | -0.1667 | -54.80% |
| 1 Month | 0.1621 | 0.36 | 0.1522 | 0.2539811 | 58,388,493 | -0.0246 | -15.18% |
| 3 Months | 0.057 | 0.36 | 0.0525 | 0.1535611 | 73,979,295 | 0.0805 | 141.23% |
| 6 Months | 0.3624 | 0.5144 | 0.0512 | 0.1507072 | 41,056,658 | -0.2249 | -62.06% |
| 1 Year | 0.68 | 0.75 | 0.0512 | 0.1642469 | 21,500,494 | -0.5425 | -79.78% |
| 3 Years | 92.25 | 228.00 | 0.0512 | 17.79 | 10,223,173 | -92.11 | -99.85% |
| 5 Years | 892.50 | 1,273.50 | 0.0512 | 62.68 | 10,388,123 | -892.36 | -99.98% |
Jaguar Health Description
| Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. |
